Natera to support Phase 1 trial of Kupando's immunotherapy in advanced skin cancers

Graviton BioScience's Investigational New Drug (IND) application for GV101 cleared for Friedreich's ataxia treatment

Laekna's New Drug Application for LAE002 (afuresertib) accepted by China's NMPA

EIT Pharma's lonafarnib New Drug Application accepted for review by US FDA for chronic hepatitis D treatment

AcuCort publishes Phase IV study results on patient use of Zeqmelit oral film

SoftOx doses first patient in SIS-03 proof-of-concept trial

BSF secures exclusive global commercialisation partnership for ETSYL

Aureka Biotechnologies raises USD100m to build biological world model for drug discovery

Kodiak Sciences enrols first patients in KSI-501 Phase 3 ALTO trial in patients with diabetic macular oedema

AbCellera reports positive Phase 2 results for menopause treatment ABCL635

Bristol Myers Squibb to invest USD2.3bn in Houston manufacturing campus

BeOne Medicines and Revolution Medicines expand oncology collaboration

Almirall partners with CrystalO to develop small molecules for medical dermatology

Sobi partners with Innate Pharma to advance lacutamab in T-cell lymphoma

Saniona grants AstronauTx worldwide rights to neurological disease programme